Fredun Pharmaceuticals Q2FY26 Concall Decoded: “Pet Projects, Profits & a Jain Dog Biscuit Revolution” 🐶💊
1. Opening Hook
When most pharma CEOs brag about curing humans, Fredun decided to heal your pets and your portfolio. From bone graft patents to Jain pet snacks (yes, really), the company is turning innovation into a lifestyle brand for Labradors and lab coats alike. The management even promised that by 2032, no pet in India will be born or die without touching a Freossi product — now that’s ambition with fur on it.
Stick around; this concall moves from biotech buzz to barking brilliance. Things only get wilder ahead.
2. At a Glance
Revenue up 35% YoY to ₹145.3 cr – Growth barked louder than expected.
EBITDA up 60% to ₹22.3 cr – Efficiency finally wagged its tail.
EBITDA margin at 15.4% – Even the CFO smiled at that decimal.
Net profit up 128% to ₹9.7 cr – The kind of double-digit growth your vet would envy.
H1FY26 revenue ₹265.2 cr, up 42% – Clearly, the pet-care economy is fetching results.
Operating cash flow turned positive – Finally, money flows smoother than pet shampoo.
3. Management’s Key Commentary
“We’ve strengthened our presence across 52 markets and expanded our foothold in the fast-growing pet care segment.” (Translation: From pills to paws, we’ll sell to anything that breathes.) 😏
“Our Palghar expansion will make us one of the largest single-location plants in India.” (Translation: We’re going big enough for your pets and their cousins.)
“We acquired One Pet Stop and Wagr.ai to build a connected pet wellness ecosystem.” (Translation: Even your dog’s Fitbit will say ‘Made by Fredun.’)
“Snacky Jain – India’s first pure Jain pet snack – sold 12 tons on preorder.” (Translation: Somewhere, a monk is feeding calcium biscuits to his corgi.) 🐕
“By FY32, over 51% of our revenue will come from the U.S.” (Translation: Desi dogs helped us dream in dollars.)
“Our goal is that no pet in India should be born or die without using Freossi.” (Translation: Move over religion, pet wellness is the new faith.) 🙏
